Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors

Details for Australian Patent Application No. 2005316668 (hide)

International Classifications

Event Publications

5 July 2007 PCT application entered the National Phase

PCT publication WO2006/065703 Priority application(s): WO2006/065703

6 September 2012 Assignment before Grant

Sunesis Pharmaceuticals, Inc. The application has been assigned to Millennium Pharmaceuticals, Inc. 2006

6 September 2012 Application Accepted

Published as AU-B-2005316668

27 September 2012 Assignment before Grant

Millennium Pharmaceuticals, Inc. The application has been assigned to Sunesis Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc. 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.